Analysis: Josh Gottheimer's sell of IBM (International Business Machines Corporation)

Assessment: Low signal

Rep. Gottheimer's sale of IBM was a delayed reaction to a highly public, disastrous preliminary earnings report released the day prior.

Member: Josh Gottheimer
Party / state: D-NJ-5
Chamber: House
Transaction: Sell
Amount: $1,001-$15,000
Ticker: IBM
Company: International Business Machines Corporation
Trade date: 2026-07-15
Disclosure date: 2026-08-10
Disclosure lag: 26 days

Executive summary

This research packet documents Rep. Josh Gottheimer’s disclosed IBM sales on 2026-07-15 (filed 2026-08-10) in the context of IBM’s public-company disclosures and the member’s reported committee schedules around the trade date. SEC filings show IBM issued an 8-K with preliminary second-quarter 2026 results on 2026-07-14 and a second-quarter results 8-K on 2026-07-22, with contemporaneous news coverage referencing client spending shifts and cybersecurity-related commentary.

Within the week of the analyzed trade, Congress.gov’s committee schedule shows Rep. Gottheimer’s committee(s) (House Financial Services and House Permanent Select Committee on Intelligence) had multiple scheduled hearings including a Digital Assets/FinTech/AI field hearing on 2026-07-14 and an intelligence-related hearing on 2026-07-15 (titles listed in the congressional_findings section). On the issuer side, IBM publicly filed an 8-K on 2026-07-14 containing an investor letter describing selected preliminary second-quarter results and citing factors that included client capex reprioritization and mention of industry-wide cybersecurity concerns; IBM subsequently filed an earnings 8-K on 2026-07-22 with second-quarter results and updated full-year expectations. The member’s user-provided trading history indicates IBM has been traded repeatedly over multiple years (16 total trades, including 7 sales), and the analyzed sale occurred in a cluster of other trades within ±1 day (CRWD buy, PANW buy, additional IBM sale, and FN sale). This packet does not include a complete accounting of IBM-mentioning legislation, full committee activity coverage over the full 120-day window, or an exhaustive USAspending award set due to a tool results-limit constraint described in research_gaps.

Timeline

2026-07-14 — IBM filed an 8-K reporting preliminary second-quarter 2026 results and included an investor letter (Exhibit 99.1).
2026-07-14 — IBM Newsroom published Arvind Krishna's letter to investors with selected preliminary Q2 2026 results and commentary including cybersecurity concerns.
2026-07-15 — Josh Gottheimer reported selling IBM (amount range $1,001-$15,000).
2026-07-16 — Same-day/adjacent activity: sale of IBM and purchases of PANW; purchase of CRWD on 2026-07-15; sale of FN on 2026-07-14 (±1 day window).
2026-07-22 — IBM filed an 8-K with Item 2.02 (Results of Operations and Financial Condition) and Exhibit 99.1 press release for second-quarter 2026 earnings and updated full-year expectations.
2026-08-10 — Trade disclosure filed date for analyzed trade.
2026-08-14 — IBM filed an 8-K with Item 9.01 (Financial Statements and Exhibits).

Independent analysis of public financial disclosures. Not financial or investment advice.

Sources

Josh Gottheimer · IBM · Trading news